2020-11-12T22:09:55-06:00 2019-12-31 346565596 ERNST & YOUNG US LLP 55 IVAN ALLEN JR BLVD NW STE 1000 ATLANTA GA 30308 990 2019-01-01 522340031 AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC AMER 2026615700 555 11TH STREET NW NO 300 WASHINGTON DC 20004 KAEL REICIN CFO 4043297934 2020-11-12 1 AERRIAL M ORR P01598400 4048748300 71.56.5.91 2020-11-12 22:03:04 ES P 6B24257654E21A06B34C5550A50F6F578516B4D0 A63253DE1BEA04382D3B085E93ACF4FD3C6520D6 2019 2021-04-22 16:20:28Z LISA A LACASSE 555 11TH STREET NW NO 300 WASHINGTON DC 20004 38019224 0 X WWW.FIGHTCANCER.ORG X 2001 DC THE AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. (ACS CAN) IS THE NONPROFIT, NONPARTISAN ADVOCACY AFFILIATE OF AMERICAN CANCER SOCIETY INC. DEDICATED TO ELIMINATING CANCER AS A MAJOR HEALTH PROBLEM. 17 17 251 99957 0 0 37801356 37183242 41675 16952 103490 633612 1500 0 37948021 37833806 291321 50000 0 0 23246010 24180768 0 81891 3089165 11531933 14964097 35069264 39276756 2878757 -1442950 11587587 8697938 4493988 3049840 7093599 5648098 X ACS CAN IS THE NONPROFIT, NONPARTISAN ADVOCACY AFFILIATE OF THE AMERICAN CANCER SOCIETY, DEDICATED TO ELIMINATING CANCER AS A MAJOR HEALTH PROBLEM. ACS CAN WORKS TO ENCOURAGE LAWMAKERS, CANDIDATES AND GOVERNMENT OFFICIALS TO SUPPORT LAWS AND POLICIES THAT WILL MAKE CANCER A TOP NATIONAL PRIORITY. ACS CAN GIVES ORDINARY PEOPLE EXTRAORDINARY POWER TO FIGHT CANCER. FOR MORE INFORMATION, VISIT WWW.FIGHTCANCER.ORG. 0 0 17254439 50000 16952 CANCER PREVENTION-ADVOCACY PROGRAMS IN SUPPORT OF PREVENTING CANCER OCCURRENCE AND REDUCING RISK. 8094310 CANCER DETECTION & TREATMENT-ADVOCACY PROGRAMS IN SUPPORT OF FINDING CANCER BEFORE IT IS CLINICALLY APPARENT AND PROVIDING INFORMATION & EDUCATION ABOUT CANCER TREATMENTS FOR CURE, RECURRENCE, SYMPTOM MANAGEMENT, & PAIN CONTROL. 6043606 CANCER PATIENT SUPPORT-ADVOCACY PROGRAMS IN SUPPORT OF PROGRAMS TO ASSIST CANCER PATIENTS & THEIR FAMILIES AND EASE THE BURDEN OF CANCER FOR THEM. 4273556 OTHER PROGRAM SERVICES ARE FOR ADVOCACY PROGRAMS IN SUPPORT OF INCREASED INVESTMENT IN CANCER RESEARCH. 4273556 35665911 0 1 1 1 0 0 0 0 0 1 0 0 1 1 0 1 1 0 0 0 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 63 0 1 251 1 0 0 0 0 1 1 0 0 0 X 17 17 0 0 0 0 1 0 1 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AZ CA CT FL GA HI IL IN KS KY MD MA MN MS NH NJ NY NC OK OR PA RI SC TN UT WI X X KAEL REICIN 4043297934 250 WILLIAMS ST NW STE 400 ATLANTA GA 30303 GARY REEDY CHIEF EXECUTIVE OFFICER 5.00 56.00 X 85225 937478 68326 CATHERINE E MICKLE FORMER CFO 0.00 56.00 X 0 554547 273297 ROBERT M KING CHIEF FINANCIAL OFFICER, OUTGOING 5.00 57.00 X 34536 393713 81331 LISA A LACASSE PRESIDENT 55.00 1.00 X 374471 0 86241 PAMELA G TRAXEL SR VP, ALLIANCE DEVELPMT & PHIL 55.00 1.00 X 261313 0 84808 JEFFREY A MARTIN VP, ADVOCACY ADMIN, TRAINING & OPS 55.00 0.00 X 186109 0 76749 KEYSHA BROOKS-COLEY SR VP, FED ADVOCACY STRTGIC ALLNCS 55.00 0.00 X 211548 0 46547 MARISSA P BROWN SR VP, STATE & LOCAL ADVOCACY 55.00 1.00 X 236286 0 21150 ERIN C O'NEILL VP, VOL ENGMT & GRSROOTS STRGIES 55.00 0.00 X 183509 0 61675 KIRSTEN A SLOAN VP, PUBLIC POLICY, STRATEGY & OPS 55.00 0.00 X 187726 0 32571 RICHARD L DEMING MD CHAIR 3.00 0.00 X X 0 0 0 SANDRA CASSESE MSN RN CNS VICE CHAIR 3.00 0.00 X X 0 0 0 WILLIAM P UNDERRINER SECRETARY 3.00 0.00 X X 0 0 0 MAUREEN MANN MS MBA FACHE TREASURER 3.00 0.00 X X 0 0 0 DANIEL P HEIST CPA ACS CHAIR OF THE BOARD 3.00 6.00 X X 0 0 0 JOHN W HAMILTON DDS IMMEDIATE PAST CHAIR 3.00 0.00 X X 0 0 0 WILLIAM ED E COULTER EDD DIRECTOR 1.00 0.00 X 0 0 0 THE HONORABLE DAN GLICKMAN DIRECTOR 1.00 0.00 X 0 0 0 BERNARD JACKVONY JD DIRECTOR 1.00 0.00 X 0 0 0 KIMBERLY JEFFRIES LEONARDPHD DIRECTOR 1.00 0.00 X 0 0 0 JOHN J MANNA JR ESQ DIRECTOR 1.00 0.00 X 0 0 0 MICHAEL T MARQUARDT DIRECTOR 1.00 3.00 X 0 0 0 SCARLOTT MUELLER MPHRNFAAN DIRECTOR 1.00 0.00 X 0 0 0 RICK Q NGO MD FACS DIRECTOR 1.00 0.00 X 0 0 0 BRUCE D WALDHOLTZ MD DIRECTOR 1.00 0.00 X 0 0 0 ROBERT E YOULE DIRECTOR 1.00 0.00 X 0 0 0 P KAY COLEMAN DIRECTOR 1.00 0.00 X 0 0 0 1760723 1885738 832695 32 1 1 0 GMMB 3050 K ST NW SUITE 100 WASHINGTON DC 20007 STRATEGIC ADVISEMENT 772022 HOME FRONT COMMUNICATION 1201 NEW YORK AVE NW SUITE 900 WASHINGTON DC 20005 STRATEGIC ADVISEMENT 526202 BETTYANDSMITH LLC 1818 N STREET NW SUITE 515 WASHINGTON DC 20036 STRATEGIC ADVISEMENT 434989 PUBLIC OPINION STRATEGIES LLC 214 NORTH FAYETTE STREET ALEXANDRIA VA 22314 STRATEGIC ADVISEMENT 337712 AVALERE HEALTH LLC PO BOX 744181 ATLANTA GA 30374 STRATEGIC ADVISEMENT 230307 12 2605325 29902718 493056 4182143 4682 37183242 PROGRAM SERVICE FEES 900099 16952 16952 16952 633612 633612 185418 2605325 185418 0 37833806 16952 0 633612 X 50000 50000 659389 398718 258410 2261 18382441 16852864 74433 1455144 1959015 1861653 918 96444 1760266 1664881 9773 85612 1419657 1294267 21193 104197 10189 7695 1916 578 23500 23500 1328337 1328337 81891 81891 1423 1423 5169188 4783909 25715 359564 1728285 1508968 219317 726450 523553 8110 194787 121124 74716 3265 43143 1824652 1676971 4027 143654 1754285 1575646 41658 136981 1941506 1788978 46272 106256 129266 97710 31556 4643 3852 79 712 PRINTING - EDU & FUND 143403 125205 18198 OTHER 52359 42501 988 8870 STATE UBI TAX 5487 5487 39276756 35665911 521680 3089165 854226 371394 8685464 6358665 489082 404366 158236 169361 1063905 882791 278824 181114 1610837 723956 11587587 8697938 2787095 2160781 821537 885356 889059 4493988 3049840 X 3189304 3669915 3904295 1978183 7093599 5648098 11587587 8697938 -1442950 -2551 0 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 359905 792 359905 359905 1 1 0 0 PART I-A, LINE 1: ACS CAN INVITED CANDIDATES RUNNING FOR PRESIDENT TO MEET WITH NATIONAL STAFF, AND ALSO OFFERED TO SHARE A BRIEFING BINDER ON CANCER ISSUES WITH EACH CAMPAIGN. IN ADDITION, ACS CAN STAFF AND VOLUNTEERS IN THE EARLY PRIMARY STATES ATTENDED DOZENS OF EVENTS WHERE THEY ASKED CANDIDATES OF BOTH PARTIES TO GO ON RECORD ABOUT CANCER ISSUES; THESE EVENTS INCLUDED BUT WERE NOT LIMITED TO A STATE FAIR, CAMPAIGN-SPONSORED PUBLIC EVENTS, HOUSE PARTIES, AND CANDIDATE FORUMS. THEY ALSO INVITED ALL CANDIDATES TO ATTEND COFFEE EVENTS WITH ACS CAN VOLUNTEERS. ACS CAN DOES NOT EXPRESSLY ADVOCATE FOR THE ELECTION OR DEFEAT OF CANDIDATES. 573092 469747 103345 483087 411241 71846 7726 1803 5923 181114 DUE FROM AFFILLIATES 723956 723956 DUE TO AFFILLIATES 318560 DEFERRED RENT 570499 889059 38301225 467419 467419 37833806 0 37833806 41845296 2568540 2568540 39276756 0 39276756 X X X X X 1 M&R STRATEGIC SERVICES INC 2120 L STREET MW 6TH FLOOR WASHINGTON DC 20037 ONLINE STRATEGY 0 0 81891 0 81891 AL AK AR CA CO CT FL GA HI IL IN KS KY ME MD MA MI MN MS MO NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT WA WI POLICY EVENT 1838178 1715889 122289 667 102722 659 4233 14008 LIGHTS OF HOPE 525741 490717 35024 29420 189 1212 4203 52 426824 398719 28105 23608 152 973 3372 2790743 2605325 185418 667 155750 1000 6418 21583 185418 0 1 OREGONIANS FOR A SMOKE FREE TOMORROW PO BOX 42307 PORTLAND OR 97242 842501983 501(C)(4) 50000 TOBACCO ADVOCACY 0 1 PART I, LINE 2: THE GRANT AGREEMENT REQUIRES NARRATIVE AND FINANCIAL REPORTS TO BE FURNISHED BY GRANTEE TO ACS CAN WITHIN 60 DAYS OF THE COMPLETION OF GRANTEE'S AUDITED FINANCIAL STATEMENTS. REPORTING CONTINUES ON AN ANNUAL BASIS UNTIL GRANTEE HAS EXPENDED ALL FUNDS TRANSFERRED UNDER THE GRANT AGREEMENT. THE NARRATIVE REPORT DESCRIBES THE PROGRESS MADE BY THE GRANTEE TOWARDS ACHIEVING THE STATED GRANT PURPOSES. THE FINANCIAL REPORT SHOWS ACTUAL EXPENDITURES AGAINST THE APPROVED BUDGET AND SHOWS THAT THE GRANTEE HAS COMPLIED WITH THE LOBBYING CAP DESCRIBED IN THE AGREEMENT. THESE EXPENDITURE/PERFORMANCE REPORTS ARE TO BE RETAINED IN THE GRANTEE'S FILES FOR A PERIOD OF NOT LESS THAN SEVEN (7) YEARS AFTER THE EXPIRATION OF THE GRANT PERIOD. 0 1 0 0 0 0 0 0 0 GARY REEDY CHIEF EXECUTIVE OFFICER 64177 705950 16817 184988 4231 46540 5569 61261 125 1371 90919 1000110 0 0 CATHERINE E MICKLE FORMER CFO 0 451829 0 85500 0 17218 0 260789 0 12508 0 827844 0 0 ROBERT M KING CHIEF FINANCIAL OFFICER, OUTGOING 27027 308105 5746 65504 1763 20104 6047 68936 512 5836 41095 468485 0 0 LISA A LACASSE PRESIDENT 334700 0 37796 0 1975 0 84843 0 1398 0 460712 0 0 0 PAMELA G TRAXEL SR VP, ALLIANCE DEVELPMT & PHIL 259228 0 0 0 2085 0 77428 0 7380 0 346121 0 0 0 JEFFREY A MARTIN VP, ADVOCACY ADMIN, TRAINING & OPS 184652 0 0 0 1457 0 64475 0 12274 0 262858 0 0 0 KEYSHA BROOKS-COLEY SR VP, FED ADVOCACY STRTGIC ALLNCS 210277 0 0 0 1271 0 46005 0 542 0 258095 0 0 0 MARISSA P BROWN SR VP, STATE & LOCAL ADVOCACY 235061 0 0 0 1225 0 14223 0 6927 0 257436 0 0 0 ERIN C O'NEILL VP, VOL ENGMT & GRSROOTS STRGIES 182066 0 0 0 1443 0 54431 0 7244 0 245184 0 0 0 KIRSTEN A SLOAN VP, PUBLIC POLICY, STRATEGY & OPS 185559 0 0 0 2167 0 25320 0 7251 0 220297 0 0 0 PART I, LINE 3 THE FILING ORGANIZATION'S TOP MANAGEMENT OFFICIAL IS AN EMPLOYEE OF A RELATED PARTY, THE AMERICAN CANCER SOCIETY, INC. (ACS, INC.). ACCORDINGLY, HIS COMPENSATION IS DETERMINED BY THE FOLLOWING METHODS: COMPENSATION COMMITTEE; INDEPENDENT COMPENSATION CONSULTANT; COMPENSATION STUDY OR SURVEY; AND APPROVAL BY THE BOARD OF COMPENSATION COMMITTEE. THE RESPONSIBILITIES OF THE COMPENSATION COMMITTEE FOR ACS, INC. ARE DETAILED IN THE FORM 990 FOR ACS, INC. PART I, LINE 4B THE FILING ORGANIZATION AND A RELATED FILING ORGANIZATION MAINTAIN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN ("SERP"), 457(B), AND 457(F) PLANS AS PART OF THE TOTAL COMPENSATION ARRANGEMENTS FOR CERTAIN EXECUTIVES. THE SERP IS DESIGNED TO RESTORE CERTAIN BENEFITS THAT ARE LOST AS A RESULT OF TAX RESTRICTIONS ON BENEFITS PAYABLE FROM THE TAX-QUALIFIED DEFINED BENEFIT RETIREMENT PLAN. THE ORGANIZATION RESTORES MATCHING CONTRIBUTION BENEFITS THAT ARE LOST AS A RESULT OF TAX RESTRICTIONS ON THE FILING ORGANIZATION'S 401(K)PLAN IN THE 457(B) AND 457(F) PLANS. AS PART OF THE COMPENSATION COMMITTEE (THE "COMMITTEE") RESPONSIBILITIES, THE COMMITTEE CONSIDERS THE NEW AND TOTAL VALUES OF ALL SERP AND 457(F) BENEFITS AS PART OF THE TOTAL COMPENSATION FOR EACH PARTICIPATING EXECUTIVE. THE COMMITTEE PROCESS IS FULLY DESCRIBED IN SCHEDULE O AS RELATED TO PART IV, LINE 15. THE SERP PLAN WAS FROZEN IN 2016, AND AS A RESULT PAYMENTS ARE NOW MADE ONLY AFTER RETIREMENT RATHER THAN IN INCREMENTAL AMOUNTS DURING THE EXECUTIVE'S SERVICE. SCHEDULE J, PART II, COLUMN C INCLUDES DEFERRED COMPENSATION RELATED TO THE ANNUAL CHANGE IN ACTUARIAL VALUE OF A QUALIFIED DEFINED BENEFIT RETIREMENT PLAN. THE CHANGE IS CAUSED BY CHANGES IN ACTUARIAL ASSUMPTIONS, WHICH ARE REQUIRED TO BE USED TO VALUE THE BENEFITS. A SIGNIFICANT DECREASE IN INTEREST RATES AND AN INCREASE IN THE LIFE EXPECTANCY OF PARTICIPANTS RESULTED IN A LARGE INCREASE IN ESTIMATED VALUE OF BENEFITS FROM THE PRIOR YEAR. PRIOR TO ACTUAL RETIREMENT, THE ACTUARIAL (ESTIMATED) VALUES CAN INCREASE OR DECREASE FROM YEAR TO YEAR DEPENDING WHETHER CERTAIN ASSUMPTIONS INCREASE OR DECREASE. FORM 990, PART VI, SECTION A, LINE 6 MEMBERS OR STOCKHOLDERS THE AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. IS A NONPROFIT CORPORATION WHOSE SOLE CORPORATE MEMBER IS THE AMERICAN CANCER SOCIETY, INC. THE BYLAWS ALSO PROVIDE FOR NON-VOTING MEMBERS. FORM 990, PART VI, SECTION A, LINE 7B DECISIONS RESERVED TO MEMBERS OR STOCKHOLDERS THE AMERICAN CANCER SOCIETY, INC. HAS VOTING RIGHTS WITH REGARD TO AMENDMENT OF THE FILING ORGANIZATION'S ARTICLES OF INCORPORATION OR TO MERGE, CONSOLIDATE, OR DISSOLVE THE FILING ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B PROCESS USED TO REVIEW THE FORM 990 MANAGEMENT, IN CONJUNCTION WITH AN INDEPENDENT ACCOUNTING FIRM, PREPARES AND REVIEWS THE FORM 990. THEN, PRIOR TO FILING WITH THE IRS, THE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS' FINANCE/AUDIT COMMITTEE FOR REVIEW DURING A REGULARLY SCHEDULED MEETING. AN ELECTRONIC COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS PRIOR TO THE FORM BEING FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C MONITORING AND ENFORCEMENT OF COMPLIANCE WITH CONFLICT OF INTEREST POLICY THE AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. MAINTAINS A WRITTEN CONFLICT OF INTEREST (COI) POLICY, WHICH IS REVIEWED BY MANAGEMENT AND THE BOARD OF DIRECTORS' AUDIT COMMITTEE AT LEAST ANNUALLY AND MODIFIED AS REQUIRED. THE BOARD OF DIRECTORS, TRUSTEES, OFFICERS, KEY EMPLOYEES, AND ALL OTHER EMPLOYEES OF THE ORGANIZATION ARE REQUIRED TO CERTIFY ANNUALLY THAT THEY HAVE READ AND UNDERSTAND THE COI POLICY AND SUBMIT A WRITTEN QUESTIONNAIRE EACH YEAR DISCLOSING ANY KNOWN CONFLICTS. THE RESPONSES TO THE QUESTIONNAIRES ARE REVIEWED BY MANAGEMENT. MANAGEMENT ALSO MONITORS ALL TRANSACTIONS DURING THE NORMAL COURSE OF BUSINESS TO IDENTIFY OTHER POTENTIAL CONFLICTS. ON A QUARTERLY BASIS, THE BOARD OF DIRECTORS' AUDIT COMMITTEE REVIEWS POTENTIAL CONFLICTS TO DETERMINE WHETHER ANY ACTUAL CONFLICTS EXIST. INDIVIDUALS WHO BELIEVE THEY ARE IN A POTENTIAL CONFLICT ARE REQUIRED TO RECUSE THEMSELVES FROM THE DELIBERATION AND DECISION-MAKING. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ARE EMPLOYEES OF THE AMERICAN CANCER SOCIETY, INC. (ACS, INC.), AND ACCORDINGLY THEIR COMPENSATION IS SUBJECT TO DETERMINATION AND REVIEW BY ACS, INC.'S COMPENSATION COMMITTEE. THE BOARD'S OVERSIGHT RESPONSIBILITIES FOR DETERMINING THE ADEQUACY AND REASONABLENESS OF THE TOTAL COMPENSATION PAID TO EMPLOYEES WHO MAY BE CHARACTERIZED AS DISQUALIFIED PERSONS WITHIN THE MEANING OF SECTION 4958 OF THE INTERNAL REVENUE CODE SHALL BE ASSIGNED TO, AND VESTED IN, THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS OF THE AMERICAN CANCER SOCIETY, INC., WHICH SHALL BE A DESIGNATED BODY OF THE CORPORATION. FORM 990, PART VI, SECTION C, LINE 19 PROCESS FOR MAKING DOCUMENTS AVAILABLE TO THE PUBLIC THE AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC BY POSTING TO THE ORGANIZATION'S WEBSITE AT WWW.FIGHTCANCER.ORG. GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G GENERAL PROGRAM OPERATIONAL SERVICES AND ACTIVITIES: PROGRAM SERVICE EXPENSES 4,783,909. MANAGEMENT AND GENERAL EXPENSES 25,715. FUNDRAISING EXPENSES 359,564. TOTAL EXPENSES 5,169,188. AMERICAN CANCER SOCIETY INC 250 WILLIAMS ST NW STE 400 ATLANTA GA 30303 131788491 ELIMINATE CANCER GA 501(C)(3) LINE 7 N/A 0 ACS DEVELOPMENT I INC 250 WILLIAMS ST NW STE 400 ATLANTA GA 30303 465439010 SUPPORT ACS GA 501(C)(3) LINE 12A, I ACS INC 0 ACS CAPITAL INC 250 WILLIAMS ST NW STE 400 ATLANTA GA 30303 465429467 SUPPORT ACS GA 501(C)(3) LINE 12A, I ACS CAN 1 ACS PRODUCTS INC 250 WILLIAMS ST NW STE 400 ATLANTA GA 30303 020651055 SUPPORT ACS GA 501(C)(3) LINE 12A, I ACS INC 0 AMERICAN CANCER SOCIETY INC PUERTO RICO 566 CALLE CABO HERMOGENES ALVERIO HATO REY PR 00918 660321594 ELIMINATE CANCER PR 501(C)(3) LINE 7 ACS INC 0 ACS DEVELOPMENT COMPANY II INC 250 WILLIAMS ST NW STE 400 ATLANTA GA 30303 821993189 SUPPORT ACS GA 501(C)(3) LINE 12A, I ACS INC 0 0 0 1 0 0 0 0 0 0 0 1 1 1 1 1 1 0 0 0 AMERICAN CANCER SOCIETY INC P 18045506 FMV AMERICAN CANCER SOCIETY INC C 29902718 FMV AMERICAN CANCER SOCIETY INC K 113048 FMV AMERICAN CANCER SOCIETY INC M 78006 FMV